Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times

INmune Bio Teams with Quantum Computing Inc. to Target New Indications for XPro

(Credit: INmune Bio)

In an industry-first convergence of quantum photonics and precision medicine, INmune Bio Inc. (NASDAQ: INMB) and Quantum Computing Inc. (NASDAQ: QUBT) have entered into a commercial collaboration to apply quantum optimization, artificial intelligence, and advanced analytics to drug discovery.

The joint effort aims to analyze vast biological datasets to identify new therapeutic targets and predictive response biomarkers for XPro (XPro1595), INmune Bio's targeted biologic currently being evaluated for Alzheimer's disease and other neuroinflammatory disorders.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.